As of 2024-12-11, the EV/EBITDA ratio of Deciphera Pharmaceuticals Inc (DCPH) is -10.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DCPH's latest enterprise value is 2,121.80 mil USD. DCPH's TTM EBITDA according to its financial statements is -204.61 mil USD. Dividing these 2 quantities gives us the above DCPH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.9x - 17.7x | 16.2x |
| Forward P/E multiples | 15.9x - 21.7x | 16.1x |
| Fair Price | (36.61) - (40.82) | (37.15) |
| Upside | -243.1% - -259.5% | -245.2% |
| Date | EV/EBITDA |